Huai Bai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Huai Bai has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
Ping Fan
19 shared publications- Bing-Wen Liu
Department of Biochemistry and Molecular Biology, West China Medical Center, Sichuan University, Chengdu 610041, Sichuan, People’s Republic of China
16 shared publications Rui Liu
15 shared publicationsYu Liu
15 shared publicationsYu Liu
12 shared publicationsBingwen Liu
Department of Biochemistry and Molecular Biology, West China School of Preclinical and Forensic Medicine, Sichuan University, Chengdu, Sichuan, PR China
10 shared publications
Latest Publications
- 1 January 2015
- Vol. 46 (1) , 108-12
[The Ala379Val polymorphism of platelet-activating factor acetylhydrolase gene in Chinese patients with pre-eclampsia].
To investigate the relationship between the Ala379Val polymorphism of the platelet-activating factor acetylhydrolase gene (PAF-AH) and pre-eclampsia (PE) in Chinese pregnant women. A total of 592 subjects (210 patients with PE and 382 healthy pregnant women) in Chengdu area were included in this study. The Ala379Val polymorphism of the PAF-AH gene was determined by PCR amplification and restriction analysis. Plasma PAF-AH and high-density lipoprotein-associated PAF-AH (H-PAF-AH) activities were measured by the trichloroacetic acid precipitation method using PAF as substrate and (3 H-acetyl) PAF as tracer. Low-density lipoprotein-associated PAF-AH (L-PAF-AH) activity was obtained by subtracting H-PAF-AH activity from plasma PAF-AH activity. The frequencies of the A and V alleles at Ala379Val site were 0.890 and 0.110 in the patient group, and 0.865 and 0.135 in control group, respectively. No significant differences in the frequencies of the genotypes and alleles were observed between the two groups (P>0.05). However, the body mass index (BMI) and the ratio of L-PAF-AH to H-PAF-AH activities were significantly higher, and H-PAF-AH activity was significantly lower, in patients with V alleles (AV + VV genotypes) compared to patients with AA homozygotes (P<0.05). The Ala379Val polymorphism of the PAF-AH gene was not associated with PE, but the V allele variation at this site might be associated with the increased BMI and the abnormal distribution of plasma PAF-AH activities in lipoproteins in patients with PE.
- 1 January 2015
- Vol. 46 (1) , 108-12
[The Ala379Val polymorphism of platelet-activating factor acetylhydrolase gene in Chinese patients with pre-eclampsia].
To investigate the relationship between the Ala379Val polymorphism of the platelet-activating factor acetylhydrolase gene (PAF-AH) and pre-eclampsia (PE) in Chinese pregnant women. A total of 592 subjects (210 patients with PE and 382 healthy pregnant women) in Chengdu area were included in this study. The Ala379Val polymorphism of the PAF-AH gene was determined by PCR amplification and restriction analysis. Plasma PAF-AH and high-density lipoprotein-associated PAF-AH (H-PAF-AH) activities were measured by the trichloroacetic acid precipitation method using PAF as substrate and (3 H-acetyl) PAF as tracer. Low-density lipoprotein-associated PAF-AH (L-PAF-AH) activity was obtained by subtracting H-PAF-AH activity from plasma PAF-AH activity. The frequencies of the A and V alleles at Ala379Val site were 0.890 and 0.110 in the patient group, and 0.865 and 0.135 in control group, respectively. No significant differences in the frequencies of the genotypes and alleles were observed between the two groups (P>0.05). However, the body mass index (BMI) and the ratio of L-PAF-AH to H-PAF-AH activities were significantly higher, and H-PAF-AH activity was significantly lower, in patients with V alleles (AV + VV genotypes) compared to patients with AA homozygotes (P<0.05). The Ala379Val polymorphism of the PAF-AH gene was not associated with PE, but the V allele variation at this site might be associated with the increased BMI and the abnormal distribution of plasma PAF-AH activities in lipoproteins in patients with PE.
- 1 January 2015
- Vol. 46 (1) , 118-22
[Interaction between GNB3 C825T and ACE I/D polymorphisms in pre-eclampsia].
To verify the hypothesis if interaction between the G protein beta3 subunit (GNB3) C825T polymorphism and angiotensin-I converting enzyme (ACE) insertion/deletion (I/D) could lead to the increased risk of pre-eclampsia. Analyses of ACE and GNB3 genotypes were performed in 188 preeclamptic patients and 273 normal pregnant controls by polymerase chain reaction (PCR) and PCR-restriction fragment length polymorphism in Chinese population, respectively. The distributions of alleles and genotypes for the GNB3 C825T and ACE I/D polymorphisms were not found to be significantly associathed with pre-eclamptic status. No significant interaction of the influence of GNB3 T allele and ACE genotypes on the risk of pre-eclampsia was observed (OR 0.439-1.203, all P>0.05). However, we found that in homozygous 825T genotype carriers with the ACE II genotype in controls diastolic blood pressure (DBP) levels showed highest [(77.61 +/- 1.26) mmHg (1 mmHg=0.133 kPa)] among other three genotype combinations [TT/ID, (70.94 +/- 1.64) mmHg; CT/ID, (73.15 +/- 0.89) mmHg; CT/DD, (72.57 +/- 2.14) mmHg] (all P<0.05). No significant effect on systolic blood pressure (SBP) or DBP levels in the patients were observed. Our data suggest no significant interaction of the GNB3 825T allele carriers with the ACE I/D polymorphism in pre-eclampsia in Chinese population in Chengdu area. However there is the interaction of the two genes on DBP levels in pregnancy women without pre-eclampsia in the population.
- 1 January 2015
- Vol. 46 (1) , 118-22
[Interaction between GNB3 C825T and ACE I/D polymorphisms in pre-eclampsia].
To verify the hypothesis if interaction between the G protein beta3 subunit (GNB3) C825T polymorphism and angiotensin-I converting enzyme (ACE) insertion/deletion (I/D) could lead to the increased risk of pre-eclampsia. Analyses of ACE and GNB3 genotypes were performed in 188 preeclamptic patients and 273 normal pregnant controls by polymerase chain reaction (PCR) and PCR-restriction fragment length polymorphism in Chinese population, respectively. The distributions of alleles and genotypes for the GNB3 C825T and ACE I/D polymorphisms were not found to be significantly associathed with pre-eclamptic status. No significant interaction of the influence of GNB3 T allele and ACE genotypes on the risk of pre-eclampsia was observed (OR 0.439-1.203, all P>0.05). However, we found that in homozygous 825T genotype carriers with the ACE II genotype in controls diastolic blood pressure (DBP) levels showed highest [(77.61 +/- 1.26) mmHg (1 mmHg=0.133 kPa)] among other three genotype combinations [TT/ID, (70.94 +/- 1.64) mmHg; CT/ID, (73.15 +/- 0.89) mmHg; CT/DD, (72.57 +/- 2.14) mmHg] (all P<0.05). No significant effect on systolic blood pressure (SBP) or DBP levels in the patients were observed. Our data suggest no significant interaction of the GNB3 825T allele carriers with the ACE I/D polymorphism in pre-eclampsia in Chinese population in Chengdu area. However there is the interaction of the two genes on DBP levels in pregnancy women without pre-eclampsia in the population.
- 1 March 2013
- Published by SAGE Publications in Genetic Testing and Molecular Biomarkers
- Vol. 17 (3) , 207-213
Genetic Variation in the OX40L/OX40 System and Plasma Lipid and Lipoprotein Levels in a Chinese Hypertriglyceridemic Population
Aims: To investigate the variations of OX40 (tumor necrosis factor receptor superfamily, member 4) and its ligand OX40L genes and their relationships with serum lipids and apolipoproteins (apo) levels in Chinese healthy individuals and patients with endogenous hypertriglyceridemia (HTG) in the Chengdu area. Methods: The genotypes and allele frequencies of the rs3850641 and rs17568 polymorphisms in the OX40L and OX40 genes were assayed by polymerase chain reaction and restriction fragment length polymorphism. Results: In the case–control study, which included 126 HTG subjects and 206 normal control subjects, the frequencies of the G allele at the rs3850641 site and the G allele at the rs17568 site in the patients were similar to those observed in the controls. In the HTG group, subjects with G allele carriers of the rs3850641 site had lower serum high-density lipoprotein cholesterol and apo AI levels as compared to those of genotype AA. In the case group, subjects with G allele carriers of the rs17568 site had higher serum low-density lipoprotein cholesterol (LDL-C) levels, while controls had lower serum total serum cholesterol and LDL-C levels. Conclusion: These results suggest that the rs3850641 and rs17568 polymorphisms in the OX40L and OX40 genes are associated with some of the lipid and lipoprotein variations in subjects with endogenous HTG and/or in the general population of Han Chinese.
- 1 March 2013
- Published by SAGE Publications in Genetic Testing and Molecular Biomarkers
- Vol. 17 (3) , 207-213
Genetic Variation in the OX40L/OX40 System and Plasma Lipid and Lipoprotein Levels in a Chinese Hypertriglyceridemic Population
Aims: To investigate the variations of OX40 (tumor necrosis factor receptor superfamily, member 4) and its ligand OX40L genes and their relationships with serum lipids and apolipoproteins (apo) levels in Chinese healthy individuals and patients with endogenous hypertriglyceridemia (HTG) in the Chengdu area. Methods: The genotypes and allele frequencies of the rs3850641 and rs17568 polymorphisms in the OX40L and OX40 genes were assayed by polymerase chain reaction and restriction fragment length polymorphism. Results: In the case–control study, which included 126 HTG subjects and 206 normal control subjects, the frequencies of the G allele at the rs3850641 site and the G allele at the rs17568 site in the patients were similar to those observed in the controls. In the HTG group, subjects with G allele carriers of the rs3850641 site had lower serum high-density lipoprotein cholesterol and apo AI levels as compared to those of genotype AA. In the case group, subjects with G allele carriers of the rs17568 site had higher serum low-density lipoprotein cholesterol (LDL-C) levels, while controls had lower serum total serum cholesterol and LDL-C levels. Conclusion: These results suggest that the rs3850641 and rs17568 polymorphisms in the OX40L and OX40 genes are associated with some of the lipid and lipoprotein variations in subjects with endogenous HTG and/or in the general population of Han Chinese.
- 12 January 2012
- Published by SAGE Publications in Genetic Testing and Molecular Biomarkers
- Vol. 16 (6) , 514-518
Association Study of Apolipoprotein L-I Lys166Glu and Ile244Met Gene Variants with Obesity in Chinese Subjects
Aims: ApoL-I is a newly found component of high-density lipoprotein, and has a potential role in lipid metabolism. This study was mainly to examine the possible association of the ApoL-I gene polymorphism with obesity and plasma lipid levels in the Chinese population. Methods: Three hundred nineteen Han Chinese (109 obese and 210 nonobese control subjects) in Chengdu area were studied using polymerase chain reaction-restriction fragment length polymorphism analysis. Results: The Lys and Glu allele frequencies of the apoL-I gene at the Lys166Glu site in obese and nonobese control groups were 0.830, 0.170 and 0.814, 0.186, respectively. The Ile and Met allele frequencies of the gene at Ile244Met site in the obese and the control groups were 0.844, 0.156 and 0.831, 0.169, respectively. The 166Glu and 244Met allele frequencies of the two polymorphisms in obese subjects were not different from those in the controls, respectively ( p >0.05). In the nonobese group, subjects with genotype Lys/Lys at the Lys166Glu site or Ile/Ile at the Ile244Met site had a higher serum mean concentration of triglyceride (TG) as compared with those of corresponding Glu or Met allele carriers ( p p Conclusion: The current study, for the first time, provides evidence that Lys166Glu and Ile244Met polymorphisms in apoL-I gene are associated with TG, apoC-III, and apoE levels in nonobese Chinese. However, these polymorphisms are not associated with obesity in the population.
- 12 January 2012
- Published by SAGE Publications in Genetic Testing and Molecular Biomarkers
- Vol. 16 (6) , 514-518
Association Study of Apolipoprotein L-I Lys166Glu and Ile244Met Gene Variants with Obesity in Chinese Subjects
Aims: ApoL-I is a newly found component of high-density lipoprotein, and has a potential role in lipid metabolism. This study was mainly to examine the possible association of the ApoL-I gene polymorphism with obesity and plasma lipid levels in the Chinese population. Methods: Three hundred nineteen Han Chinese (109 obese and 210 nonobese control subjects) in Chengdu area were studied using polymerase chain reaction-restriction fragment length polymorphism analysis. Results: The Lys and Glu allele frequencies of the apoL-I gene at the Lys166Glu site in obese and nonobese control groups were 0.830, 0.170 and 0.814, 0.186, respectively. The Ile and Met allele frequencies of the gene at Ile244Met site in the obese and the control groups were 0.844, 0.156 and 0.831, 0.169, respectively. The 166Glu and 244Met allele frequencies of the two polymorphisms in obese subjects were not different from those in the controls, respectively ( p >0.05). In the nonobese group, subjects with genotype Lys/Lys at the Lys166Glu site or Ile/Ile at the Ile244Met site had a higher serum mean concentration of triglyceride (TG) as compared with those of corresponding Glu or Met allele carriers ( p p Conclusion: The current study, for the first time, provides evidence that Lys166Glu and Ile244Met polymorphisms in apoL-I gene are associated with TG, apoC-III, and apoE levels in nonobese Chinese. However, these polymorphisms are not associated with obesity in the population.
- 1 January 2011
- Vol. 42 (1) , 19-23
[Analysis of the FABP2 gene Ala54Thr polymorphism in non-obese and obese Chinese].
To investigate the fatty acid-binding protein 2 gene (FABP2) Ala54Thr polymorphism and its relationship to obesity in Chinese population. Three hundred and ninety three subjects (272 non-obese and 121 obese individuals) from a population of Chinese Han nationality in Chengdu area were studied using PCR-restriction fragment length polymorphisms (PCR-RFLPs). Serum lipids were measured by enzymatic kits and apolipoproteins A I, A II, B100, C II, CIII and E were measured by the RID kits. The frequencies of Ala and Thr allele at Ala54Thr site in obese and non-obese groups were 71.5%, 28.5%, and 71.1%, 28.9%, respectively. No significant difference in the allele frequencies between the two groups was observed (P > 0.05). In the obese group, subjects with Thr allele (AlaThr +ThrThr genotype carriers)had higher serum triglyceride (TG) concentrations than those with genotype AlaAla (P < 0.05). Similar results were observed in obese male subgroup, when male and female subgroups were further separated. In addition, obese males with AlaThr had lower HDL-C levels than those with genotype AlaAla. No significant difference of lipid and apolipoprotein levels was observed in obese females or non-obese group. The Ala54Thr polymorphism in the FABP2 gene was not associated with obesity in Chinese Han population of Chengdu area. However, it may be associated with serum TG, HDL-C levels, with some gender-specific effect, in this population.
- 1 January 2011
- Vol. 42 (1) , 19-23
[Analysis of the FABP2 gene Ala54Thr polymorphism in non-obese and obese Chinese].
To investigate the fatty acid-binding protein 2 gene (FABP2) Ala54Thr polymorphism and its relationship to obesity in Chinese population. Three hundred and ninety three subjects (272 non-obese and 121 obese individuals) from a population of Chinese Han nationality in Chengdu area were studied using PCR-restriction fragment length polymorphisms (PCR-RFLPs). Serum lipids were measured by enzymatic kits and apolipoproteins A I, A II, B100, C II, CIII and E were measured by the RID kits. The frequencies of Ala and Thr allele at Ala54Thr site in obese and non-obese groups were 71.5%, 28.5%, and 71.1%, 28.9%, respectively. No significant difference in the allele frequencies between the two groups was observed (P > 0.05). In the obese group, subjects with Thr allele (AlaThr +ThrThr genotype carriers)had higher serum triglyceride (TG) concentrations than those with genotype AlaAla (P < 0.05). Similar results were observed in obese male subgroup, when male and female subgroups were further separated. In addition, obese males with AlaThr had lower HDL-C levels than those with genotype AlaAla. No significant difference of lipid and apolipoprotein levels was observed in obese females or non-obese group. The Ala54Thr polymorphism in the FABP2 gene was not associated with obesity in Chinese Han population of Chengdu area. However, it may be associated with serum TG, HDL-C levels, with some gender-specific effect, in this population.
- 1 January 2011
- Vol. 42 (1) , 24-8
[The -108 C/T polymorphism in paraoxonase 1 gene in Chinese patients with polycystic ovary syndrome].
To investigate the relationship between the -108 C/T polymorphism in the promoter of paraoxonase 1 (PON1) gene and polycystic ovarian syndrome (PCOS) in Chinese women. A total of six hundred and sixty one subjects (346 patients with PCOS and 315 healthy control women) in Chengdu area were included in this study. The -108 C/T polymorphism in PON1 gene was studied using polymerase chain reaction and restriction fragment length polymorphism analysis (PCR-RFLP). Total testosterone (TT), luteinizing hormone (LH), follicle stimulating hormone (FSH) and plasma insulin (INS) were determined by chemiluminescent method. Plasma glucose (GLU), total cholesterol (TC), triglycerides (TG), high density lipoprotein cholesterol (HDL-C), and low density lipoprotein cholesterol (LDL-C) were measured by enzymatic assay. Serum malondialdehyde (MDA) levels were measured by spectrophometry at 532 nm using micro-MDA detection kits. The frequencies of CC, CT and TT genotypes at PON1 -108 C/T site in PCOS and control groups were 0.283 and 0.324, 0.517 and 0.492, 0.199 and 0.184, respectively, and the frequencies of C and T alleles in both groups were 0.542 and 0.570, 0.458 and 0.430, respectively. There were no significant differences in the frequencies of the genotypes and alleles between PCOS and control groups (P > 0.05). In the control group, the subjects with genotype CT had higher F-G scores and plasma glucose levels at 2 h during OGTT (75 g glucose) when compared with those of genotype CC (P < 0.05). Higher FSH level and MDA concentration also observed in those of genotype TT by compared with those of CC genotype (P < 0.05). The differences in FSH, GLU120 and MDA levels remained significant after adjustment for age and BMI (P = 0.006, 0.033 and 0.047, respectively). In the PCOS group, the patients with genotype CT had higher atherogenic index (AI) when compared with those of genotype CC (P = 0.038), but this difference was not significant after adjustment for age and BMI (P = 0.053). This study indicated that the -108 C/T polymorphism in the promoter of PON1 gene was associated with hormonal levels, glucose metabolism and oxidative stress in the control women, but not associated with PCOS in Chinese women of Chengdu area.
- 1 January 2011
- Vol. 42 (1) , 24-8
[The -108 C/T polymorphism in paraoxonase 1 gene in Chinese patients with polycystic ovary syndrome].
To investigate the relationship between the -108 C/T polymorphism in the promoter of paraoxonase 1 (PON1) gene and polycystic ovarian syndrome (PCOS) in Chinese women. A total of six hundred and sixty one subjects (346 patients with PCOS and 315 healthy control women) in Chengdu area were included in this study. The -108 C/T polymorphism in PON1 gene was studied using polymerase chain reaction and restriction fragment length polymorphism analysis (PCR-RFLP). Total testosterone (TT), luteinizing hormone (LH), follicle stimulating hormone (FSH) and plasma insulin (INS) were determined by chemiluminescent method. Plasma glucose (GLU), total cholesterol (TC), triglycerides (TG), high density lipoprotein cholesterol (HDL-C), and low density lipoprotein cholesterol (LDL-C) were measured by enzymatic assay. Serum malondialdehyde (MDA) levels were measured by spectrophometry at 532 nm using micro-MDA detection kits. The frequencies of CC, CT and TT genotypes at PON1 -108 C/T site in PCOS and control groups were 0.283 and 0.324, 0.517 and 0.492, 0.199 and 0.184, respectively, and the frequencies of C and T alleles in both groups were 0.542 and 0.570, 0.458 and 0.430, respectively. There were no significant differences in the frequencies of the genotypes and alleles between PCOS and control groups (P > 0.05). In the control group, the subjects with genotype CT had higher F-G scores and plasma glucose levels at 2 h during OGTT (75 g glucose) when compared with those of genotype CC (P < 0.05). Higher FSH level and MDA concentration also observed in those of genotype TT by compared with those of CC genotype (P < 0.05). The differences in FSH, GLU120 and MDA levels remained significant after adjustment for age and BMI (P = 0.006, 0.033 and 0.047, respectively). In the PCOS group, the patients with genotype CT had higher atherogenic index (AI) when compared with those of genotype CC (P = 0.038), but this difference was not significant after adjustment for age and BMI (P = 0.053). This study indicated that the -108 C/T polymorphism in the promoter of PON1 gene was associated with hormonal levels, glucose metabolism and oxidative stress in the control women, but not associated with PCOS in Chinese women of Chengdu area.
- 1 September 2010
- Vol. 41 (5) , 771-4, 802
[Directed migration and morphological changes of cultured trophoblast cells in small electric fields].
To study the effect of physiological direct current electric fields (dcEF) on the migration and morphology of trophoblast cells. The trophoblast cells (HTR8) were exposed to dcEF at 100 mV/mm and 200 mV/mm for 5 and 24 hours. The cell images were recorded and analyzed by image analyzer. Trophoblast cells cultured in medium containing 20% calf serum showed significant galvanotropism, including directed migration and orientation in the electric fields with a field strength of 100 mV/mm and 200 mV/mm. The cells showed obvious anode migration and enhanced migration rates compared with the non-EF stimulated cells. The directed migration was serum dependent. No significant cell migration occurred in the serum free medium under dcEF stimulation. The trophoblast cells showed morphological changes such as elongation under dcEF stimulation. Physiological direct current electrical fields may induce directed migration of trophoblast cells and this response is serum dependent. The morphological change featured with elongation is evident under dcEF stimulation.
- 1 September 2010
- Vol. 41 (5) , 771-4, 802
[Directed migration and morphological changes of cultured trophoblast cells in small electric fields].
To study the effect of physiological direct current electric fields (dcEF) on the migration and morphology of trophoblast cells. The trophoblast cells (HTR8) were exposed to dcEF at 100 mV/mm and 200 mV/mm for 5 and 24 hours. The cell images were recorded and analyzed by image analyzer. Trophoblast cells cultured in medium containing 20% calf serum showed significant galvanotropism, including directed migration and orientation in the electric fields with a field strength of 100 mV/mm and 200 mV/mm. The cells showed obvious anode migration and enhanced migration rates compared with the non-EF stimulated cells. The directed migration was serum dependent. No significant cell migration occurred in the serum free medium under dcEF stimulation. The trophoblast cells showed morphological changes such as elongation under dcEF stimulation. Physiological direct current electrical fields may induce directed migration of trophoblast cells and this response is serum dependent. The morphological change featured with elongation is evident under dcEF stimulation.
- 1 September 2010
- Vol. 41 (5) , 814-7
[Vasohibin and VEGF protein levels in placentae from pregnancies complicated by severe pre-eclampsia].
To study the expression of vasohibin and vascular endothelial growth factor (VEGF) in placentae from normal pregnancies and pregnancies complicated by severe pre-eclampsia. Placental tissues were obtained by caesarean section for 30 cases of pregnancy with severe pre-eclampsia and 30 cases of matched normal pregnancies. Protein levels of vasohibin and VEGF in placental tissue were quantified by Western blot analysis. Immunohistochemistry was used to determine the localization of the vasohibin protein in placental tissue. The mean value of vasohibin in normal pregnant women was 0.91 +/- 0.12, and in women with severe pre-eclampsia was 0.58 +/- 0.09. These values were statistically different between the two groups (P < 0.05). Moreover, VEGF expression was also significantly reduced in the patients compared with the controls (0.65 +/- 0.20 vs. 0.24 +/- 0.13, P < 0.05). There was a significant positive correlation between vasohibin and VEGF levels (r = 0.262, P < 0.05). Immunolocalization of vasohibin in normal term villous placenta was specifically expressed in the vascular endothelial cells, and no positive staining of other cell types such as syncytiotrophoblast cells, cytotrophoblast cells, and chorionic villi interstitial cells was found. These results suggest that reduced vasohibin and VEGF expression may be responsible, at least in part, for the impaired vascular development which occurs in the pre-eclampsia.
- 1 September 2010
- Vol. 41 (5) , 814-7
[Vasohibin and VEGF protein levels in placentae from pregnancies complicated by severe pre-eclampsia].
To study the expression of vasohibin and vascular endothelial growth factor (VEGF) in placentae from normal pregnancies and pregnancies complicated by severe pre-eclampsia. Placental tissues were obtained by caesarean section for 30 cases of pregnancy with severe pre-eclampsia and 30 cases of matched normal pregnancies. Protein levels of vasohibin and VEGF in placental tissue were quantified by Western blot analysis. Immunohistochemistry was used to determine the localization of the vasohibin protein in placental tissue. The mean value of vasohibin in normal pregnant women was 0.91 +/- 0.12, and in women with severe pre-eclampsia was 0.58 +/- 0.09. These values were statistically different between the two groups (P < 0.05). Moreover, VEGF expression was also significantly reduced in the patients compared with the controls (0.65 +/- 0.20 vs. 0.24 +/- 0.13, P < 0.05). There was a significant positive correlation between vasohibin and VEGF levels (r = 0.262, P < 0.05). Immunolocalization of vasohibin in normal term villous placenta was specifically expressed in the vascular endothelial cells, and no positive staining of other cell types such as syncytiotrophoblast cells, cytotrophoblast cells, and chorionic villi interstitial cells was found. These results suggest that reduced vasohibin and VEGF expression may be responsible, at least in part, for the impaired vascular development which occurs in the pre-eclampsia.
- Open Access
- 25 February 2010
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 25 (5) , 1288-1294
Identification of the G994T polymorphism in exon 9 of plasma platelet-activating factor acetylhydrolase gene as a risk factor for polycystic ovary syndrome
Low-grade chronic inflammation and greater risks of cardiovascular diseases are often present in patients with polycystic ovary syndrome (PCOS). Platelet-activating factor (PAF) acetylhydrolase (PAF-AH) hydrolyzes and inactivates PAF and PAF-like oxidized phospholipids that are potent lipid mediators involved in inflammation and atherosclerosis. Deficiency of this enzyme is caused by a missense mutation (G994 → T) in exon 9 of the plasma PAF-AH gene. The aim of the study was to investigate a possible association of this polymorphism with the risk of PCOS and to evaluate the effects of the genotype on the activity and distribution of PAFAH in Chinese patients. A total of 661 subjects (346 patients with PCOS and 315 healthy control women) from a population of Chinese Han nationality in Chengdu area were included in this study. PAFAH G994T genotype was studied using PCR and restriction fragment length polymorphism analysis. Total plasma PAF-AH, high-density lipoprotein (HDL)-associated PAF-AH (H-PAF-AH) and low-density lipoprotein (LDL)-associated PAF-AH (L-PAF-AH) activities were measured by the trichloroacetic acid precipitation procedure using [3H-acetyl] PAF and PAF C-16 as a substrate. The prevalence of the mutant genotype (GT + TT) was significantly more frequent in patients with PCOS than in control subjects (12.7 versus 6.0%, P = 0.003). Genotype (GT + TT) remained a significant predictor for PCOS (P = 0.020) in prognostic models including age, body mass index, insulin resistance index, triglyceride, HDL and LDL as covariates. There was a significant difference in plasma PAF-AH, L-PAF-AH and H-PAF-AH activities between GG and GT genotypes in both the patient and control groups. The ratio of L-PAF-AH to H-PAF-AH activities was significantly higher after adjustment for multiple variables in patients with GT genotype compared with patients with GG genotype (P = 0.003). There were no significant differences in clinical, biochemical and metabolic parameters according to PAFAH G994T genotyping in patients with PCOS and control women. The G994T polymorphism in PAFAH gene may be one of the genetic determinants for PCOS in Chinese Han women.
- 25 February 2010
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 25 (5) , 1288-1294
Open AccessIdentification of the G994T polymorphism in exon 9 of plasma platelet-activating factor acetylhydrolase gene as a risk factor for polycystic ovary syndrome
Low-grade chronic inflammation and greater risks of cardiovascular diseases are often present in patients with polycystic ovary syndrome (PCOS). Platelet-activating factor (PAF) acetylhydrolase (PAF-AH) hydrolyzes and inactivates PAF and PAF-like oxidized phospholipids that are potent lipid mediators involved in inflammation and atherosclerosis. Deficiency of this enzyme is caused by a missense mutation (G994 → T) in exon 9 of the plasma PAF-AH gene. The aim of the study was to investigate a possible association of this polymorphism with the risk of PCOS and to evaluate the effects of the genotype on the activity and distribution of PAFAH in Chinese patients. A total of 661 subjects (346 patients with PCOS and 315 healthy control women) from a population of Chinese Han nationality in Chengdu area were included in this study. PAFAH G994T genotype was studied using PCR and restriction fragment length polymorphism analysis. Total plasma PAF-AH, high-density lipoprotein (HDL)-associated PAF-AH (H-PAF-AH) and low-density lipoprotein (LDL)-associated PAF-AH (L-PAF-AH) activities were measured by the trichloroacetic acid precipitation procedure using [3H-acetyl] PAF and PAF C-16 as a substrate. The prevalence of the mutant genotype (GT + TT) was significantly more frequent in patients with PCOS than in control subjects (12.7 versus 6.0%, P = 0.003). Genotype (GT + TT) remained a significant predictor for PCOS (P = 0.020) in prognostic models including age, body mass index, insulin resistance index, triglyceride, HDL and LDL as covariates. There was a significant difference in plasma PAF-AH, L-PAF-AH and H-PAF-AH activities between GG and GT genotypes in both the patient and control groups. The ratio of L-PAF-AH to H-PAF-AH activities was significantly higher after adjustment for multiple variables in patients with GT genotype compared with patients with GG genotype (P = 0.003). There were no significant differences in clinical, biochemical and metabolic parameters according to PAFAH G994T genotyping in patients with PCOS and control women. The G994T polymorphism in PAFAH gene may be one of the genetic determinants for PCOS in Chinese Han women.